Debasmita Dutta

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Mohiuddin Quadir · 3 shared papers, 2021–2025 · strength 0.54
   • Paper Targeted nanoencapsulation of tunicamycin reduces toxicity while improving its therapeutic effectiveness in pancreatic … DOI 10.1016/j.omton.2025.201047↗
   • Paper pH-responsive targeted nanoparticles release ERK-inhibitor in the hypoxic zone and sensitize free gemcitabine in mutant… DOI 10.1371/journal.pone.0297749↗
   • Paper pH-Sensitive Nanodrug Carriers for Codelivery of ERK Inhibitor and Gemcitabine Enhance the Inhibition of Tumor Growth i… DOI 10.1021/acs.molpharmaceut.0c00499↗
2. Sushanta K. Banerjee · 3 shared papers, 2021–2025 · strength 0.54
   • Paper Targeted nanoencapsulation of tunicamycin reduces toxicity while improving its therapeutic effectiveness in pancreatic … DOI 10.1016/j.omton.2025.201047↗
   • Paper pH-responsive targeted nanoparticles release ERK-inhibitor in the hypoxic zone and sensitize free gemcitabine in mutant… DOI 10.1371/journal.pone.0297749↗
   • Paper pH-Sensitive Nanodrug Carriers for Codelivery of ERK Inhibitor and Gemcitabine Enhance the Inhibition of Tumor Growth i… DOI 10.1021/acs.molpharmaceut.0c00499↗
3. Snigdha Banerjee · 3 shared papers, 2021–2025 · strength 0.54
   • Paper Targeted nanoencapsulation of tunicamycin reduces toxicity while improving its therapeutic effectiveness in pancreatic … DOI 10.1016/j.omton.2025.201047↗
   • Paper pH-responsive targeted nanoparticles release ERK-inhibitor in the hypoxic zone and sensitize free gemcitabine in mutant… DOI 10.1371/journal.pone.0297749↗
   • Paper pH-Sensitive Nanodrug Carriers for Codelivery of ERK Inhibitor and Gemcitabine Enhance the Inhibition of Tumor Growth i… DOI 10.1021/acs.molpharmaceut.0c00499↗
4. Priyanka Ray · 2 shared papers, 2021–2024 · strength 0.31
   • Paper pH-responsive targeted nanoparticles release ERK-inhibitor in the hypoxic zone and sensitize free gemcitabine in mutant… DOI 10.1371/journal.pone.0297749↗
   • Paper pH-Sensitive Nanodrug Carriers for Codelivery of ERK Inhibitor and Gemcitabine Enhance the Inhibition of Tumor Growth i… DOI 10.1021/acs.molpharmaceut.0c00499↗
5. Daniel J. Mettman · 1 shared paper, 2025 · strength 0.22
   • Paper Targeted nanoencapsulation of tunicamycin reduces toxicity while improving its therapeutic effectiveness in pancreatic … DOI 10.1016/j.omton.2025.201047↗
6. Stefan H. Bossmann · 1 shared paper, 2025 · strength 0.22
   • Paper Targeted nanoencapsulation of tunicamycin reduces toxicity while improving its therapeutic effectiveness in pancreatic … DOI 10.1016/j.omton.2025.201047↗
7. Arnab Ghosh · 1 shared paper, 2024 · strength 0.20
   • Paper pH-responsive targeted nanoparticles release ERK-inhibitor in the hypoxic zone and sensitize free gemcitabine in mutant… DOI 10.1371/journal.pone.0297749↗
8. Megan Orr · 1 shared paper, 2021 · strength 0.11
   • Paper pH-Sensitive Nanodrug Carriers for Codelivery of ERK Inhibitor and Gemcitabine Enhance the Inhibition of Tumor Growth i… DOI 10.1021/acs.molpharmaceut.0c00499↗
9. Gauthami Nair · 1 shared paper, 2021 · strength 0.11
   • Paper pH-Sensitive Nanodrug Carriers for Codelivery of ERK Inhibitor and Gemcitabine Enhance the Inhibition of Tumor Growth i… DOI 10.1021/acs.molpharmaceut.0c00499↗
10. Katie M. Reindl · 1 shared paper, 2021 · strength 0.11
    • Paper pH-Sensitive Nanodrug Carriers for Codelivery of ERK Inhibitor and Gemcitabine Enhance the Inhibition of Tumor Growth i… DOI 10.1021/acs.molpharmaceut.0c00499↗
11. Sanku Mallik · 1 shared paper, 2021 · strength 0.11
    • Paper pH-Sensitive Nanodrug Carriers for Codelivery of ERK Inhibitor and Gemcitabine Enhance the Inhibition of Tumor Growth i… DOI 10.1021/acs.molpharmaceut.0c00499↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.